ltztherapeutics

LTZ Therapeutics is a clinical-stage immunotherapy biotechnology company developing novel myeloid engager therapeutics for cancer treatment. Its platform focuses on the direct engagement of myeloid cells with target cells to boost anti-tumor immunity, with lead candidate LTZ-232 receiving FDA IND clearance in July 2026 for advanced metastatic colorectal cancer and other solid tumors. The company operates from Redwood City, USA and Shenzhen, China. It is a portfolio company of Qiming and was added to the API Evangelist network as a stub for enrichment; it publishes no developer API surface.

ltztherapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Immunotherapy, Oncology, and Therapeutics.

ltztherapeutics’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyImmunotherapyOncologyTherapeuticsPharmaceuticals

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.3/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/ltztherapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: ltztherapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/ltztherapeutics.png
name: ltztherapeutics
description: LTZ Therapeutics is a clinical-stage immunotherapy biotechnology company developing novel myeloid engager therapeutics
  for cancer treatment. Its platform focuses on the direct engagement of myeloid cells with target cells to boost anti-tumor
  immunity, with lead candidate LTZ-232 receiving FDA IND clearance in July 2026 for advanced metastatic colorectal cancer
  and other solid tumors. The company operates from Redwood City, USA and Shenzhen, China. It is a portfolio company of Qiming
  and was added to the API Evangelist network as a stub for enrichment; it publishes no developer API surface.
url: https://raw.githubusercontent.com/api-evangelist/ltztherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Immunotherapy
- Oncology
- Therapeutics
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ltztherapeutics-domain-security.yml
- type: Website
  url: https://ltztherapeutics.com
- type: Blog
  url: https://ltztherapeutics.com/news/
- type: Support
  url: https://ltztherapeutics.com/contact/
- type: PrivacyPolicy
  url: https://ltztherapeutics.com/privacy_policy/
- type: TermsOfService
  url: https://ltztherapeutics.com/term_of_use/
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1